DNA methylation regulates Sirtuin 1 expression in osteoarthritic chondrocytes

Area of Science:

• Molecular Biology
• Epigenetics
• Osteoarthritis Research

Background:

• Sirtuin 1 (SIRT1) is a key longevity factor with chondroprotective roles.
• Downregulation of SIRT1 is implicated in osteoarthritis (OA) progression.

Purpose of the Study:

• Investigate the role of DNA methylation in regulating SIRT1 expression and activity in human OA chondrocytes.
• Determine the impact of DNA methylation on SIRT1's protective functions in OA.

Main Methods:

• Analyzed SIRT1 promoter methylation in normal and OA chondrocytes using bisulfite sequencing.
• Assessed CCAAT/enhancer binding protein alpha (C/EBPα) binding via ChIP assay.
• Evaluated effects of 5-Aza-2'-Deoxycytidine (5-AzadC) on SIRT1 expression, NF-κB pathway, and inflammatory mediators.

Main Results:

• OA chondrocytes exhibit SIRT1 promoter hypermethylation, correlating with reduced SIRT1 expression and C/EBPα binding.
• 5-AzadC treatment reversed hypermethylation, upregulated SIRT1, and restored C/EBPα activity.
• SIRT1 upregulation reduced NF-κB activation and expression of inflammatory mediators (IL-1β, IL-6) and matrix-degrading enzymes (MMP-1, MMP-9).

Conclusions:

• DNA methylation significantly suppresses SIRT1 in OA chondrocytes, contributing to OA pathogenesis.
• Demethylation strategies that restore SIRT1 may offer a therapeutic approach for OA by reducing inflammation and cartilage breakdown.